Related Experiment Video
Updated: Jan 19, 2026
Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus
Published on: May 16, 2025
Treatment of lupus nephritis with cyclosporine - an outcome analysis
Zuzana Rihova1, Zdenka Vankova, Dita Maixnerova
1Nephrology Unit, 1st Medical Faculty, Charles University, Prague, Czech Republic. zrihova@centrum.cz
Background:
The optimal therapy for lupus nephritis (LN), including the role of cyclosporine (CsA), still lacks scientifically valid clinical experience. We evaluated the efficacy of CsA in the induction and maintenance treatment of patients with biopsy-proven LN.
Patients And Methods:
A total of 31 patients (25 women, 6 men, mean age 29.5 years) were enrolled in the study. The majority had proliferative LN. The mean follow-up was 85.6 +/- 24.7 months.
Results:
CsA was used as first-line treatment in 38.7% of patients and as second-line treatment in 61.3% of patients. Complete remission was achieved in 93.5% of patients. The relapse rate was 45.2%. The mean disease-free interval was 33 months. At the end of follow-up, a total of 67.9% of the patients were in remission. The treatment led to significant improvement in proteinuria (p = 0.001) and stabilization of renal function.
Conclusion:
CsA might be an appropriate and a less toxic alternative drug for LN both as a first-choice and rescue therapy.
Related Concept Videos
05:39Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus
04:34Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
05:28Analysis of Fecal Microbiota Dynamics in Lupus-Prone Mice Using a Simple, Cost-Effective DNA Isolation Method
12:03Myocardial Infarction and Functional Outcome Assessment in Pigs
02:24Predicting Reaction Outcomes
01:13Outcomes of Glycolysis
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...